Modulation of oligonucleotide CpGmediated immune stimulation by positional modification of nucleosides

Details for Australian Patent Application No. 2006200811 (hide)

Owner Idera Pharmaceuticals, Inc.

Inventors Agrawal, Sudhir

Agent Freehills

Pub. Number AU-A-2006200811

Parent 783687

Filing date 24 February 2006

Wipo publication date 23 March 2006

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

16 March 2006 Complete Application Filed

23 March 2006 Application Open to Public Inspection

  Published as AU-A-2006200811

13 September 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006200812-3-dimensional steroscopic display systems

2006200810-Steam turbine power plant